Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.
Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, 1 A-B Rue Thomas Edison, L-1445, Strassen, Luxembourg. firstname.lastname@example.org.
Distinguishing lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has a tremendous therapeutic implication. Sometimes, the commonly used immunohistochemistry (IHC) markers fail to discriminate between them, urging for the identification of new diagnostic biomarkers.
Br. J. Cancer 2018;119(5):580-590.
Pubmed ID: 30078843